Skip to main content
. 2017 Mar 3;6(2):65–74. doi: 10.1159/000457793

Table 1.

Immunocytochemistry markers studied to characterize thyroid nodules

TGF-α Mig-6 XRCC4 Chromogranin A PPAR-γ
LlG4 Ku80 NDRG2 CEA HGF
WDR3 IGFBP7 ERs Calcitonin C-met
PDGF FOXE1 β-Catenin TROP-2 CD30
Galectin-3 TTF1 IL-6 p16 CaT12
u-PAR MMPs NAT2 p21 E-CAD
RAD2 IL-10 MT1G p27 CD56
MUCs CRABP1 Serpin-A BCL-2 IGF-1
TIMP1 PTEN NM23 BAX IGF-1R
p63 KAI1 IGFBP5 BCL-XL HMV-CK
NATH CCND1 MYC Cyclin-A FRA-1
ERBB2 hNIS c-FOS Cyclin-D1 HMGA2
Fibronectin-1 HBME1 CITED-1 Cyclin-B1 MRC2
CK-19 B-RAF p53 EphB4 SFN
CD44 Ki-67 RET EphB6 NF-kB
PGK1 CD117 HER2 KAP-1 EGFR
MUC-1 COX-2 SSTR-2 CXCR4 PCNA
TPO DPP4 HKIII HMWCK MIB-1
CD57 CD15 GLUT1 IL-6R YY1
C1orf24 ITM-1 DDIT3 ARG2 HMGI(Y)